AzTrials
AzTrials

VaricoceleNCT07684963

Effect of Varicocelectomy on Spermatogenic Cell Count and Semen Parameters

A study testing Subinguinal Microsurgical Varicocelectomy in people with Varicocele and Male Infertility, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This study aims to evaluate how varicocele surgery (varicocelectomy) affects the number of immature sperm cells (spermatogenic cells) found in the semen of infertile men. Varicocele, an abnormal dilation of veins in the scrotum, is a common cause of male infertility that can negatively impact semen quality and overall… Read more about this study

Who is it for?
Ages 20 to 45 years, men only
Conditions the study is for
Varicocele, Male Infertility, Infertility
What is being tested?
Subinguinal Microsurgical Varicocelectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Aug 2026to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Infertile married males diagnosed with clinical varicocele.
  • Age between 20-45 years.
  • Patients indicated for varicocelectomy according to standard clinical guidelines.
  • Abnormal or suboptimal semen parameters on at least two semen analyses.

Who cannot join

  • Azoospermic patients (complete absence of sperm in semen).
  • History of previous varicocelectomy or scrotal surgery.
  • Presence of other known causes of infertility (e.g., genetic abnormalities, obstructive azoospermia).
  • Active genital infection or systemic infection affecting semen analysis.
  • Use of medications affecting spermatogenesis within the last 3 months (e.g., testosterone, chemotherapy).
  • Chronic systemic diseases known to affect fertility (e.g., uncontrolled diabetes, liver failure).
  • Severe leukocytospermia as confirmed by peroxidase (Endtz) test exceeding WHO reference limits.
  • Pus cell > 1 million/ml by peroxidase.

About this study

Official title: Seminal Spermatogenic Cell Count Pre and Post Varicocelectomy: Relation to Seminal Parameters

This study aims to evaluate how varicocele surgery (varicocelectomy) affects the number of immature sperm cells (spermatogenic cells) found in the semen of infertile men. Varicocele, an abnormal dilation of veins in the scrotum, is a common cause of male infertility that can negatively impact semen quality and overall testicular function. While surgery is widely performed to improve standard semen parameters, this study specifically investigates its impact on the shedding of immature germ cells into the seminal fluid, which can be an indicator of impaired sperm production.

Researchers will enroll 40 infertile married men, aged 20 to 45, who have been diagnosed with a clinical varicocele and exhibit abnormal semen parameters. All participants will undergo a single surgical intervention known as a subinguinal microsurgical varicocelectomy. To measure the effects of the surgery, participants will undergo careful semen analysis before the procedure, and again at 3 and 6 months postoperatively. The primary goal is to track changes in the spermatogenic cell count and abnormal sperm morphology, and to explore how these changes correlate with conventional semen parameters like sperm concentration, motility, and vitality.

Read the detailed description

Male factor infertility contributes as the sole factor in approximately 20-25% of infertile couples. While semen analysis remains the cornerstone for evaluating male infertility , conventional parameters may not fully reflect underlying functional and molecular alterations. Varicocele, characterized by abnormal dilatation and tortuosity of the pampiniform venous plexus, is one of the most common correctable causes of male infertility. The pathological changes associated with varicocele can adversely affect the seminiferous epithelium, leading to defective spermatogenesis and an increased sloughing of immature germ cells (spermatogenic cells) into the seminal fluid. According to World Health Organization (WHO) recommendations, the presence of these spermatogenic cells is clinically relevant as it reflects impaired spermatogenesis and testicular dysfunction.

This prospective interventional study aims to evaluate changes in seminal spermatogenic cell counts and conventional semen parameters following surgical correction. Participants will undergo a subinguinal microsurgical varicocelectomy. During the procedure, the spermatic cord is delivered and examined under 5-10X microscopic magnification. The internal spermatic artery is carefully identified, utilizing an intraoperative USG probe if necessary, and dissected free of surrounding structures. Internal spermatic veins and cremasteric veins are ligated, while testicular arteries, cremasteric arteries, lymphatic vessels, and the vas deferens are preserved.

To assess the surgical outcomes, semen samples will be collected after 3-5 days of sexual abstinence preoperatively (at least a week apart, utilizing the second sample) and postoperatively at 3 and 6 months. The differentiation of seminal round cells into leukocytes and spermatogenic cells will be conducted using combined morphological and enzymatic methods. Semen smears will be stained with Papanicolaou stain and examined under light microscopy to identify spermatogenic cells based on nuclear morphological features. A peroxidase (Endtz) test will concurrently be used to differentiate peroxidase-positive leukocytes from peroxidase-negative spermatogenic cells. The spermatogenic cell concentration will be quantified using a Neubauer hemocytometer according to the WHO 2021 manual equation.

Being tested
Subinguinal Microsurgical Varicocelectomy
Keywords
Spermatogenic Cells, Semen Parameters, Immature Germ Cells, Semen Analysis, Sperm Morphology, Round Cells
Medical subject headings
Varicocele, Infertility, Male, Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Subinguinal Microsurgical VaricocelectomyProcedure or surgery

    A 3-4 cm subinguinal incision will be made below the external ring. Under 5-10X microscopic magnification, the internal spermatic artery will be identified and preserved. The internal spermatic veins and cremasteric veins, with the exception of vasal veins, will be ligated. The testicular arteries, cremasteric arteries, cremaster muscle fibers, nerves, lymphatic vessels, and vas deferens will be preserved before the spermatic cord is returned and the incision is closed.

Study groups in NCT07684963
Study groupRoleWhat they receive
Microsurgical VaricocelectomyExperimentalInfertile married males aged 20-45 with clinical varicocele and abnormal semen parameters will form a single study arm. All participants will undergo a subinguinal microsurgical varicocelectomy. The surgical technique involves opening the spermatic fasciae under microscopic magnification (up to 10X), identifying and preserving the internal spermatic artery, and ligating the internal spermatic and cremasteric veins. Semen analysis, including spermatogenic cell quantification using combined morphological and enzymatic methods, will be conducted preoperatively and at 3 and 6 months postoperatively.
Receives: Procedure: Subinguinal Microsurgical Varicocelectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Seminal Spermatogenic Cell Count

    Spermatogenic cell concentration will be quantified using a Neubauer hemocytometer and expressed as x10⁶ cells/mL.

    Measured: Preoperatively, and at 3 and 6 months postoperatively.

Secondary outcomes (1)
  1. Change in Sperm Concentration

    The change in sperm concentration will be analyzed and measured in 10⁶/ml according to the World Health Organization (WHO) Laboratory Manual.

    Measured: Preoperatively, and at 3 and 6 months postoperatively.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionAug 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07684963
Sponsor's protocol ID
Varicocelectomy & Semen Cells
Status last verified
Jun 2026
First submitted
28 Jun 2026
Last updated
6 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Subinguinal Microsurgical Varicocelectomy in people with Varicocele and Male Infertility, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Seminal Spermatogenic Cell Count (time frame: Preoperatively, and at 3 and 6 months postoperatively.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in